International Journal of Reproductive BioMedicine
Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Sciences of Yazd
Vol. 18, No. 3, 2020, pp. 187-192
Bioline Code: rm20023
Full paper language: English
Document type: Research Article
Document available free of charge
International Journal of Reproductive BioMedicine, Vol. 18, No. 3, 2020, pp. 187-192
© Copyright 2020 - Wiweko et al.
Correlation of anti-Müllerian hormone levels with metabolic syndrome events in polycystic ovary syndrome: A cross-sectional study|
Wiweko, Budi; Handayani, Lieke Koes; Harzif, Achmad Kemal; Pratama, Gita; Muharam, Raden; Hestiantoro, Andon & Sumapraja, Kanadi
Background: Various endocrine disorders have been reported in women of reproductive age, 10% of which is affected by polycystic ovary syndrome (PCOS).
Objective: This study aimed to evaluate the correlation of anti-Müllerian hormone
(AMH) levels with the metabolic syndrome in patients with PCOS.
Materials and Methods: This cross-sectional study employed a consecutive sampling method using medical records from January 2013 to December 2017 at Dr. Cipto Mangunkusumo General Hospital polyclinic and Yasmin in vitro fertilization Clinic
(Kencana), Jakarta, Indonesia. The primary outcome of the study was the AMH
levels as independent variable correlated with metabolic syndrome. The secondary
outcome was also the AMH levels correlated with each PCOS phenotype. The
tertiary outcome was each PCOS phenotype as independent variable correlated with
Results: Women with phenotype 1 of PCOS had a median AMH level of 13.92 (range: 3.88-34.06) ng/ml. 21% patients had metabolic syndrome, with a median AMH level 7.65 (3.77-20.20) ng/ml, higher than the women without metabolic syndrome (p = 0.38). The
most frequent phenotype in women with PCOS was phenotype 4, oligo- or anovulation
and polycystic ovary morphology (OA/PCOM) in 41.3%. The most frequent phenotype
in women with metabolic syndrome was phenotype 1, OA + PCOM + hyperandrogenism
Conclusion: All PCOS phenotypes exhibited significant correlations with the AMH
level. Phenotype 1 (OA + PCOM + hyperandrogenism) was associated with the highest
AMH level and was significantly associated with metabolic syndrome.
Anti-Müllerian hormone; Metabolic syndrome; Polycystic ovary syndrome.
Alternative site location: http://www.ijrm.ir